Connor, Clark & Lunn Investment Management (CC&L)
ATOS icon

Connor, Clark & Lunn Investment Management (CC&L)’s Atossa Therapeutics ATOS Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$165K Buy
2025
Q1 		$127K Hold
2024
Q4 		$179K Sell
2024
Q3 		$304K Sell
2024
Q2 		$249K Buy
2024
Q1 		$276K Buy
2023
Q4 		$106K Sell
2023
Q3 		$98.4K Buy
2023
Q1 		– Sell
2022
Q4 		$9.5K Buy